Tag: Heart / Stroke-Related: High Cholesterol
2015 to 2018 Saw High Total Cholesterol for 11.4 Percent of U.S. Adults
Highest prevalence of high total cholesterol in those aged 40 to 59; prevalence similar by race/ethnicity
Public Policy Recs Updated for Familial Hypercholesterolemia
Goals include enhancing awareness of familial hypercholesterolemia as a global public health issue
APO(a)-LRX Found to Reduce Lipoprotein(a) Levels
Dose-dependent reduction found in patients with elevated lipoprotein(a) levels, cardiovascular disease
Non-HDL Cholesterol Levels Linked to Long-Term ASCVD Risk
Fifty percent reduction in non-HDLC concentration linked to reduced risk for CVD event by age 75 years
Non-HDL Cholesterol Levels Linked to Long-Term ASCVD Risk
Fifty percent reduction in non-HDLC concentration linked to reduced risk for CVD event by age 75 years
AHA: Lower-Target LDL Level Beneficial After Stroke, TIA
Subsequent risk for CV events lower among patients with ischemic stroke, TIA, evidence of atherosclerosis
AHA: Predictors for Meeting LDL-C, SBP Goals ID’d in ISCHEMIA
Older age, male sex, high-intensity statin use, lower baseline LDL-C predict LDL-C goal attainment
AHA: Many With Atherosclerotic CVD Not Meeting LDL-C Goals
Of those patients receiving only a statin, 67.0 percent did not achieve recommended LDL-C goal
Cholesterol Levels Have Been Dropping Since 2013 Guidelines
Total cholesterol, triglycerides, LDL-C levels decreased; proportion of eligible adults taking statins increased
AI Model Helps ID Those at Risk for Familial Hypercholesterolemia
Model may identify more who are at risk while substantially reducing the number of people screened
